Clinical trial

Mechanisms Linking Obsessive-Compulsive Symptoms and Tobacco Dependence

Name
28IR-0063
Description
This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.
Trial arms
Trial start
2019-02-04
Estimated PCD
2023-03-23
Trial end
2023-03-23
Status
Completed
Phase
Early phase I
Treatment
Cigarette 1
Cigarette containing between 0mg nicotine and the conventional amount of nicotine (0.8mg)
Arms:
Condition 1, Condition 3
Cigarette 2
Cigarette containing between 0mg nicotine and the conventional amount of nicotine (0.8mg)
Arms:
Condition 2, Condition 4
Patch 1
A patch containing between 0mg nicotine and the conventional amount of nicotine (21mg)
Arms:
Condition 1, Condition 2
Patch 2
A patch containing between 0mg nicotine and the conventional amount of nicotine (21mg)
Arms:
Condition 3, Condition 4
Size
221
Primary endpoint
Smoking Urge
Throughout study completion, an average of two weeks.
Eligibility criteria
Inclusion Criteria: * At least 21 years old * Daily smoking at least 2 years Exclusion Criteria: * Currently pregnant or breastfeeding.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'CROSSOVER', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 221, 'type': 'ACTUAL'}}
Updated at
2023-07-13

1 organization

4 products

3 indications

Product
Cigarette
Indication
Smoking
Product
Patch 1
Product
Patch 2